Related references
Note: Only part of the references are listed.Deoxycholic acid as a molecular scaffold for tyrosyl-DNA phosphodiesterase 1 inhibition: A synthesis, structure-activity relationship and molecular modeling study
Oksana V. Salomatina et al.
STEROIDS (2021)
New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1
Nadezhda S. Dyrkheeva et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Synthesis of Methoxy-, Methylenedioxy-, Hydroxy-, and Halo-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors and Their Biological Activity for Drug-Resistant Cancer
De-Xuan Hu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Novel Tdp1 Inhibitors Based on Adamantane Connected with Monoterpene Moieties via Heterocyclic Fragments
Aldar A. Munkuev et al.
MOLECULES (2021)
New Hybrid Compounds Combining Fragments of Usnic Acid and Monoterpenoids for Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibition
Nadezhda S. Dyrkheeva et al.
BIOMOLECULES (2021)
Small molecule microarray identifies inhibitors of tyrosyl-DNA phosphodiesterase 1 that simultaneously access the catalytic pocket and two substrate binding sites
Xue Zhi Zhao et al.
CHEMICAL SCIENCE (2021)
Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor Therapy
Tatyana M. Khomenko et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Usnic Acid Conjugates with Monoterpenoids as Potent Tyrosyl-DNA Phosphodiesterase 1 Inhibitors
Olga Luzina et al.
JOURNAL OF NATURAL PRODUCTS (2020)
A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade
Xiaoxia Liang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
The Development of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors. Combination of Monoterpene and Adamantine Moieties via Amide or Thioamide Bridges
Arina A. Chepanova et al.
APPLIED SCIENCES-BASEL (2019)
New Hydrazinothiazole Derivatives of Usnic Acid as Potent Tdp1 Inhibitors
Aleksander S. Filimonov et al.
MOLECULES (2019)
Novel Inhibitors of DNA Repair Enzyme TDP1 Combining Monoterpenoid and Adamantane Fragments
Evgcnii S. Mozhaitsev et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2019)
Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topotecan on in vivo tumor models
A. L. Zakharenko et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
The Development of a Weighted Index to Optimise Compound Libraries for High Throughput Screening
Chatchakorn Eurtivong et al.
MOLECULAR INFORMATICS (2019)
Stereoselective Synthesis, Synthetic and Pharmacological Application of Monoterpene-Based 1,2,4-and 1,3,4-Oxadiazoles
Timea Gonda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Pharmacophore requirements for HIV-1 reverse transcriptase inhibitors that selectively Freeze the pre-translocated complex during the polymerization catalytic cycle
Cyrus M. Lacbay et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors
Konstantin Yu. Ponomarev et al.
BIOORGANIC CHEMISTRY (2018)
Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors
Oksana V. Salomatina et al.
MOLECULES (2018)
Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles
Nebojsa Pavlovic et al.
FRONTIERS IN PHARMACOLOGY (2018)
Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2)
Ping Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2
Peter Hornyak et al.
BIOCHEMICAL JOURNAL (2016)
New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties
Tatyana Khomenko et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Isoquinoline-1,3-diones as Selective Inhibitors of Tyrosyl DNA Phosphodiesterase II (TDP2)
Jayakanth Kankanala et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Tyrosyl-DNA Phosphodiesterase 1 Inhibitors: Usnic Acid Enamines Enhance the Cytotoxic Effect of Camptothecin
Alexandra Zakharenko et al.
JOURNAL OF NATURAL PRODUCTS (2016)
Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety
Alexandra Zakharenko et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Targeting DNA damage response in cancer therapy
Noriko Hosoya et al.
CANCER SCIENCE (2014)
Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2)
Yves Pommier et al.
DNA REPAIR (2014)
Design, Synthesis, and Biological Evaluation of O-2-Modified Indenoisoquinolines as Dual Topoisomerase I-Tyrosyl-DNA Phosphodiesterase I Inhibitors
Peng-Cheng Lv et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Synthesis and Biological Evaluation of Indenoisoquinolines That Inhibit Both Tyrosyl-DNA Phosphodiesterase I (Tdp1) and Topoisomerase I (Top1)
Martin Conda-Sheridan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Toxoflavins and Deazaflavins as the First Reported Selective Small Molecule Inhibitors of Tyrosyl-DNA Phosphodiesterase II
Ali Raoof et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Biochemical Characterization of Human Tyrosyl-DNA Phosphodiesterase 2 (TDP2/TTRAP) A Mg2+/Mn2+-DEPENDENT PHOSPHODIESTERASE SPECIFIC FOR THE REPAIR OF TOPOISOMERASE CLEAVAGE COMPLEXES
Rui Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Repairs DNA Damage Induced by Topoisomerases I and II and Base Alkylation in Vertebrate Cells
Junko Murai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Wine Compounds as a Source for HTS Screening Collections. A Feasibility Study
Feng Zhu et al.
MOLECULAR INFORMATICS (2012)
Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors
Shar-yin N. Huang et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase
Thomas S. Dexheimer et al.
NUCLEIC ACIDS RESEARCH (2010)
Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS
Oliver Korb et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and Related Novel Steroid Derivatives as Tyrosyl-DNA Phosphodiesterase (Tdp1) Inhibitors
Thomas S. Dexheimer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Benchmarking the reliability of QikProp. Correlation between experimental and predicted values
Leukothea Ioakimidis et al.
QSAR & COMBINATORIAL SCIENCE (2008)
Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1
Smitha Antony et al.
NUCLEIC ACIDS RESEARCH (2007)
General and targeted statistical potentials for protein-ligand interactions
WTM Mooij et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
Evaluation of combination chemotherapy: Integration of nonlinear regression, curve shift, isobologram, and combination index analyses
L Zhao et al.
CLINICAL CANCER RESEARCH (2004)
Improved protein-ligand docking using GOLD
ML Verdonk et al.
PROTEINS-STRUCTURE FUNCTION AND GENETICS (2003)
Share Paper
